Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment

被引：4
|
作者：
Noble, Paul
Albera, Carlo
Kirchgaessler, Klaus-Uwe
Gilberg, Frank
Petzinger, Ute
Costabel, Ulrich
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Interstitial lung disease;
D O I：
10.1183/13993003.congress-2016.OA1809
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
OA1809
引用
收藏
页数：2
相关论文
共 50 条
  • [21] ANTACID THERAPY AND DISEASE PROGRESSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) UNDER PIRFENIDONE TREATMENT
    Kreuter, M.
    Spagnolo, P.
    Wuyts, W.
    Renzoni, E.
    Koschel, D.
    Bonella, F.
    Maher, T. M.
    Kolb, M.
    Weycker, D.
    Kirchgassler, K.
    Costabel, U.
    THORAX, 2016, 71 : A58 - A58
  • [22] Antiacid Therapy And Disease Progression In Patients With Idiopathic Pulmonary Fibrosis (ipf) Under Pirfenidone Treatment
    Kreuter, M.
    Spagnolo, P.
    Wuyts, W.
    Renzoni, E.
    Koschel, D.
    Maher, T. M.
    Kolb, M.
    Weycker, D.
    Kirchgaessler, K. -U.
    Costabel, U.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [23] Molecular Modulation of Treatment Response of Idiopathic Pulmonary Fibrosis (IPF) Patients Following Pirfenidone Therapy
    O'Callaghan, G.
    Khan, K. A.
    McCarthy, Y.
    Houston, A. M.
    Subramaniam, A.
    Elshafi, M.
    Bourke, L.
    Plant, B. J.
    Henry, M. T.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S523 - S524
  • [24] Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
    Albera, Carlo
    Costabel, Ulrich
    Fagan, Elizabeth A.
    Glassberg, Marilyn K.
    Gorina, Eduard
    Lancaster, Lisa
    Lederer, David J.
    Nathan, Steven D.
    Spirig, Dominique
    Swigris, Jeff J.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 843 - 851
  • [25] Lung function status of idiopathic pulmonary fibrosis (IPF) patients and referral for lung transplantation
    Mogulkoc, N
    Brutsche, M
    Egan, JJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A51 - A51
  • [26] Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
    Takaiwa, Takuya
    Tachibana, Hiromasa
    Arita, Machiko
    Ishida, Tadashi
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [27] Pirfenidone Is Efficacious In Patients With Idiopathic Pulmonary Fibrosis (ipf) And Mild Restrictive Disease
    Albera, C.
    Bradford, W. Z.
    Costabel, U.
    Fagan, E. A.
    Glaspole, I.
    Glassberg, M. K.
    Gorina, E.
    Kardatzke, D.
    King, T. E.
    Lancaster, L.
    Lederer, D. J.
    Nathan, S. D.
    Pereira, C.
    Spirig, D.
    Swigris, J. J.
    Valeyre, D.
    Noble, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [28] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Flaherty, K.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [29] Late Breaking Abstract - Effectiveness and tolerability of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF) from a large Italian practice cohort
    Vancheri, Carlo
    Sebastiani, Alfredo
    Rottoli, Paola
    Luppi, Fabrizio
    Harari, Sergio
    Ghirardini, Alessandra
    Kirchgaessler, Klaus-Uwe
    Tomassetti, Sara
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [30] Changes in lung function and mortality risk in patients with idiopathic pulmonary fibrosis (IPF)
    Oldham, Justin M.
    Neely, Megan L.
    Wojdyla, Daniel
    Gulati, Mridu
    Li, Peide
    Patel, Divya
    Palmer, Scott M.
    Todd, Jamie L.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
12345